Evidence map›Paper›PMID 31529327›Full record

ArticleInternational urogynecology journal2020

A long-term comparative study of Uphold™ transvaginal mesh kit against anterior colporrhaphy.

Moshe Gillor, Susanne Langer, Hans Peter Dietz

Abstract read
PubMed Publisher
In one paragraph

Article in International urogynecology journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Moshe GillorSydney Medical School Nepean, Nepean Hospital, Penrith, NSW, 2750, Australia. moshegillor@gmail.com.ORCID 0000-0002-9814-8040
Susanne LangerSydney Medical School Nepean, Nepean Hospital, Penrith, NSW, 2750, Australia.
Hans Peter DietzSydney Medical School Nepean, Nepean Hospital, Penrith, NSW, 2750, Australia.ORCID 0000-0002-2211-6149
Nepean Hospital · AUKaplan Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction and hypothesisCystocele recurrence remains a major challenge. Anterior colporrhaphy (AC) offers variable success rates that are mostly poorer than native-tissue repairs in other compartments. We compared outcomes after the use of Uphold™ transvaginal mesh kit and AC.

methodsA retrospective external audit including patients after Uphold™ mesh implantation (2010-2016) analysed against previously published data obtained in identical fashion after AC at the same hospital (2002-2005). Patients underwent an interview, clinical examination and 4D-translabial ultrasound. Offline analysis was performed blinded against all other data.

resultsOf 264 patients after mesh and 242 patients after AC, we saw 82 (31%) and 83 (34%), after a median interval of 3.9 years (range 0.4-7.3). Mean age was 64 years (34-86), mean body mass index was 27.7 kg/m

conclusionsThis analysis of two audit projects suggests that the transvaginal Uphold™ mesh kit may confer some advantages over AC for cystocele repair.

Indexed as

CystocelePelvic Organ ProlapseSurgical MeshAgedFemaleHumansMiddle AgedPregnancyRetrospective StudiesTreatment OutcomeAnterior colporrhaphyCystoceleMesh augmentationProlapseTransperineal ultrasoundUphold

Identifiers

PMID31529327
OpenAlexW2974420190

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.